Chronic cutaneous lupus flare induced by systemic 5-fluorouracil

Journal of Dermatological Treatment

Volumn 17, Issue 1, 2006, Pages 51-53

  Kluger, N ^a   Bessis, D ^a   Guillot, B ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

5 fluorouracil; Adverse drug reaction; Chronic cutaneous lupus

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; HYDROXYCHLOROQUINE;

ADULT; ARTICLE; BREAST ADENOCARCINOMA; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG ERUPTION; FEMALE; HUMAN; MACULOPAPULAR RASH; PRIORITY JOURNAL; SKIN LUPUS ERYTHEMATOSUS; SKIN PRURITUS; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LUPUS ERYTHEMATOSUS, DISCOID; MIDDLE AGED;

EID: 32644489658     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630500475591     Document Type: Article

References (7)

1. Guillot B, Bessis D, Dereure O. Mucocutaneous side effects of antineoplastic chemotherapy. Expert Opin Drug Saf. 2004;3:579-87.
2. Bernstein T. Skin reactions to 5-fluorouracil. N Engl J Med. 1977;297:337-8.
3. Pramatarov KD. Drug-induced lupus erythematosus. Clin Dermatol. 1998;16:367-77.
4. Yoshimasu T, Hiroi A, Uede K, Furukawa F. Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT). Eur J Dermatol. 2001;11:54-7.
5. Moazzam N, Malik AA, Mehdi SA, Potti A. Treatment side effects. Case 3. Fluorouracil-induced exacerbation of systemic lupus erythematosus. J Clin Oncol. 2002;20:3032-4.
6. Dudley K, Micetich K, Massa MC. Erythema with features of seborrheic dermatitis and lupus erythematosus associated with systemic 5-fluorouracil. Cutis. 1987;39:64-6.
7. Yoshimasu T, Nishide T, Seo N, Hiroi A, Ohtani T, Uede K, et al. Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus. Clin Exp Immunol. 2004;136:245-54.